Answers are grounded in this paper and cite their sources.
Treatment with drotrecogin alfa activated significantly reduces mortality in patients with severe sepsis and may be associated with an increased risk of bleeding.
No takes yet. Share an insight, caveat, or question.
Bernard et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: